Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -4454.21% is 41% below its 5-year average of -3165.66%, near the high end of its 5-year range (-14346.98%–-1180.54%).
49.29% above its 12-month average of -8783.99%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -10741.51%.
OPERATING MARGIN
-4454.21%
OPERATING MARGIN AVG TTM
-8783.99%
OPERATING MARGIN AVG 3Y
-5299.75%
OPERATING MARGIN AVG 5Y
-3165.66%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+49.29%
CURRENT VS 3Y AVG
+15.95%
CURRENT VS 5Y AVG
-40.70%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 679 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Absci Corporation
Market Cap
$1.84B
Operating Margin
-4454.21%
TTM Avg
-8783.99%
3Y Avg
-5299.75%
5Y Avg
-3165.66%
Market Cap
$1.84B
Operating Margin
2.61%
TTM Avg
3.43%
3Y Avg
5.52%
5Y Avg
6.07%
Market Cap
$1.83B
Operating Margin
-22.08%
TTM Avg
-25.82%
3Y Avg
-28.50%
5Y Avg
-19.36%
Market Cap
$1.88B
Operating Margin
50.14%
TTM Avg
6.82%
3Y Avg
-32.12%
5Y Avg
-473.91%
Market Cap
$1.82B
Operating Margin
29.46%
TTM Avg
25.49%
3Y Avg
21.64%
5Y Avg
22.06%
Market Cap
$1.89B
Operating Margin
-1.12%
TTM Avg
-4.89%
3Y Avg
-11.52%
5Y Avg
-13.12%
Market Cap
$1.79B
Operating Margin
-737.04%
TTM Avg
-849.82%
3Y Avg
-849.82%
5Y Avg
-849.82%
Market Cap
$1.90B
Operating Margin
-873.87%
TTM Avg
-1020.17%
3Y Avg
-1557.98%
5Y Avg
-1038.65%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Absci Corporation (ABSI) | $1.84B | -4454.21% | -8783.99% | -5299.75% | -3165.66% |
| Astrana Health, Inc. (ASTH)vs › | $1.84B | 2.61% | 3.43% | 5.52% | 6.07% |
| Novocure Ltd (NVCR)vs › | $1.83B | -22.08% | -25.82% | -28.50% | -19.36% |
| Azenta, Inc. (AZTA)vs › | $1.87B | -3.49% | -3.57% | -5.95% | -5.03% |
| Novavax, Inc. (NVAX)vs › | $1.88B | 50.14% | 6.82% | -32.12% | -473.91% |
| LeMaitre Vascular, Inc. (LMAT)vs › | $1.82B | 29.46% | 25.49% | 21.64% | 22.06% |
| BioLife Solutions, Inc. (BLFS)vs › | $1.89B | -1.12% | -4.89% | -11.52% | -13.12% |
| Generate Biomedicines, Inc. (GENB)vs › | $1.79B | -737.04% | -849.82% | -849.82% | -849.82% |
| Agios Pharmaceuticals, Inc. (AGIO)vs › | $1.90B | -873.87% | -1020.17% | -1557.98% | -1038.65% |
| Establishment Labs Holdings Inc. (ESTA)vs › | $1.95B | -18.48% | -24.30% | -28.12% | -27.55% |
Gross Margin
-319.4%
Operating Margin
-4454.2%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -10741.51% |
| 2026-03-31 | -14346.98% |
| 2025-12-31 | -5560.31% |
| 2025-09-30 | -7977.25% |
| 2025-06-30 | -5293.93% |
| 2025-03-31 | -2351.91% |
| 2024-12-31 | -4477.29% |
| 2024-09-30 | -1698.71% |
| 2024-06-30 | -2104.02% |
| 2024-03-31 | -2616.70% |
| 2023-12-31 | -7319.23% |
| 2023-09-30 | -3132.12% |
| 2023-06-30 | -1276.74% |
| 2023-03-31 | -1929.47% |
| 2022-12-31 | -1354.72% |
| 2022-09-30 | -1180.54% |
| 2022-06-30 | -2882.93% |
| 2022-03-31 | -3516.85% |
| 2021-12-31 | -1808.26% |
| 2021-09-30 | -1373.75% |
| 2021-06-30 | -2292.86% |
| 2021-03-31 | -1048.73% |
| 2020-12-31 | -169.83% |
| 2020-09-30 | -367.25% |
| 2020-06-30 | -498.94% |
| 2020-03-31 | -435.31% |
